Covid-19: Post-vaccination coronavirus cases miniscule

Data released Wednesday shows that per 10,000 people, the rate of infections among persons who have taken either the first or second dose of Bharat Biotech's Covaxin or Serum Institute's Covishield is extremely low

Published: Apr 22, 2021 12:14:47 PM IST

 

Click here to see Forbes India's comprehensive coverage on the Covid-19 situation and its impact on life, business and the economy‚Äč

Check out our end of season subscription discounts with a Moneycontrol pro subscription absolutely free. Use code EOSO2021. Click here for details.

Post Your Comment
Required
Required, will not be published
All comments are moderated
Photo of the Day: Spiderman, spiderman
Is India ready for home schooling?